Saudi Hospital IN Hajjah(shh) Pharmaceutical Import Profile — Yemen (DGFT 2022–2026)

Name: Saudi Hospital IN Hajjah(shh) Pharmaceutical Import Records from India — 2 Products, $126.0K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Saudi Hospital IN Hajjah(shh) — Pharmaceutical Importer Profile (2026) | 2 Products, $126.0K Trade | TransData Nexus

Import Portfolio — Top 2 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Captopril	Cardiovascular	$67.7K	6	0.5%	11
2	Glibenclamide	Advanced Diabetes Medications	$58.2K	4	0.1%	10

Saudi Hospital IN Hajjah(shh) imports 2 pharmaceutical products across 2 categories into Yemen totaling $126.0K.

Saudi Hospital IN Hajjah(shh) — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Saudi Hospital in Hajjah (SHH) is a prominent healthcare institution located in Hajjah Governorate, Yemen. Established to provide comprehensive medical services to the local population, SHH operates as a hospital offering a wide range of healthcare services. The hospital is situated on Al-Shari' Al-'Aam Street in Hajjah City District, at an elevation of approximately 1,691 meters.

In addition to its primary healthcare services, SHH functions as a pharmaceutical importer, sourcing finished pharmaceutical formulations from India. Between 2022 and 2026, SHH imported a total of $126,000 USD worth of pharmaceutical products from India, comprising 10 shipments across two therapeutic categories. The top products imported include Captopril and Glibenclamide, primarily used in cardiovascular and advanced diabetes treatments, respectively. This strategic sourcing underscores SHH's commitment to enhancing the quality and availability of essential medications for its patients.

2Distribution Network

While specific details about SHH's warehouse locations and logistics capabilities are not publicly disclosed, the hospital's role as a pharmaceutical importer suggests a structured distribution network within Yemen. Given its central location in Hajjah Governorate, SHH likely serves as a key distribution point for medical supplies, ensuring timely delivery to various healthcare facilities and pharmacies across the region. The hospital's established infrastructure and experience in managing pharmaceutical imports indicate a robust logistics system capable of handling the complexities of medical supply distribution.

3Industry Role

SHH's position in Yemen's pharmaceutical supply chain is multifaceted. Primarily, it acts as a hospital providing direct medical care to the community. Simultaneously, by importing pharmaceutical products, SHH also functions as a pharmaceutical buyer, sourcing essential medications from international suppliers to meet the needs of its patients. This dual role enhances its influence in the local healthcare sector, enabling SHH to ensure the availability of critical medications and maintain a high standard of care.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Saudi Hospital IN Hajjah(shh)

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

SHH's pharmaceutical imports are exclusively sourced from India, indicating a high level of supplier concentration. This single-source dependency could pose risks, such as supply chain disruptions due to geopolitical issues, regulatory changes, or logistical challenges. However, the consistent volume of imports and the hospital's established relationship with its Indian supplier suggest a stable and reliable partnership. To mitigate potential risks, SHH may consider diversifying its supplier base or establishing contingency plans to ensure uninterrupted access to essential medications.

2Supply Chain Resilience

The resilience of SHH's Indian supply chain is crucial for maintaining a steady supply of pharmaceuticals. While specific details about backup suppliers and formulation diversity are not publicly available, the hospital's consistent import patterns indicate a well-established and dependable supply chain. To enhance resilience, SHH could explore partnerships with additional suppliers and diversify its product formulations. Additionally, evaluating alternative shipping routes and ensuring compliance with international regulatory standards can further strengthen the supply chain's robustness.

3Strategic Implications

Importing Pharmaceuticals into Yemen — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Yemen

1Regulatory Authority & Framework

Yemen's pharmaceutical imports are regulated by the Ministry of Public Health and Population, which oversees the registration, importation, and distribution of pharmaceutical products. Key legislation governing these imports includes the Customs Law No. 14 of 1990 and its amendments, which outline the procedures and requirements for importing goods into Yemen. Additionally, the Law No. 5 of 2020 exempts certain pharmaceutical production inputs from customs duties, facilitating the importation of essential medical supplies.

2Import Licensing & GMP

To import pharmaceutical products into Yemen, companies must obtain an import license from the Ministry of Public Health and Population. This process involves registering the company with the Ministry and ensuring compliance with Good Manufacturing Practice (GMP) standards. Yemen recognizes GMP certificates from reputable international bodies, including the World Health Organization (WHO) and the Pharmaceutical Inspection Co-operation Scheme (PIC/S). Importers must also secure wholesale distribution authorization to legally distribute pharmaceutical products within the country.

3Quality & Labeling

Saudi Hospital IN Hajjah(shh) — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

SHH's focus on importing cardiovascular and advanced diabetes medications aligns with the prevalent health concerns in Yemen. The high incidence of cardiovascular diseases and diabetes in the region drives the demand for effective treatments. By sourcing these specific therapeutic areas, SHH addresses critical health needs, enhancing patient outcomes and contributing to the overall health infrastructure of Yemen.

2Sourcing Profile

SHH's sourcing strategy emphasizes the importation of generic drugs, particularly in the cardiovascular and diabetes therapeutic categories. This approach allows the hospital to provide cost-effective treatments without compromising on quality. India's robust pharmaceutical manufacturing sector, known for its adherence to international quality standards, makes it an ideal sourcing partner for SHH's procurement needs.

3Market Positioning

By importing and distributing essential medications, SHH serves a critical segment of Yemen's healthcare market, focusing on hospital-based care. The hospital's strategic sourcing and distribution ensure that patients have access to necessary treatments, positioning SHH as a key player in the healthcare supply chain within the region.

Seller's Guide — How to Become a Supplier to Saudi Hospital IN Hajjah(shh)

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to collaborate with SHH, given the hospital's consistent import patterns and focus on specific therapeutic areas. Potential gaps in SHH's current sourcing may include the need for additional suppliers to mitigate risks associated with single-source dependency. Indian exporters can explore these opportunities by ensuring compliance with Yemeni import regulations and maintaining high-quality standards to meet SHH's requirements.

2Requirements & Qualifications

Indian exporters aiming to supply SHH must obtain a Certificate of Pharmaceutical Products (COPP) from a recognized authority, such as the U.S. FDA or the WHO. This certificate must be legalized for use in Yemen to be accepted by the Ministry of Public Health and Population. Additionally, exporters must ensure that their products comply with Yemeni GMP standards and that labeling is in Arabic, providing clear and accurate information to consumers.

3How to Approach

Frequently Asked Questions — Saudi Hospital IN Hajjah(shh)

What products does Saudi Hospital IN Hajjah(shh) import from India?

Saudi Hospital IN Hajjah(shh) imports 2 pharmaceutical products across 2 categories. Top imports: Captopril ($67.7K), Glibenclamide ($58.2K).

What is Saudi Hospital IN Hajjah(shh)'s total pharmaceutical import value?

Saudi Hospital IN Hajjah(shh)'s total pharmaceutical import value from India is $126.0K, based on 10 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Saudi Hospital IN Hajjah(shh) focus on?

Saudi Hospital IN Hajjah(shh) imports across 2 categories. The largest: Cardiovascular (53.8%), Advanced Diabetes Medications (46.2%).

Get Full Saudi Hospital IN Hajjah(shh) Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Profile aggregates 2 company name variants from customs records. For current shipment-level data, contact TransData Nexus.

Saudi Hospital IN Hajjah(shh)

Saudi Hospital IN Hajjah(shh) — Import Portfolio & Supplier Network

What Products Does Saudi Hospital IN Hajjah(shh) Import?

Top Products by Import Value

Saudi Hospital IN Hajjah(shh) Therapeutic Categories — 2 Specializations